TABLE 2.
Baseline data of participants.
| Indices | Group (N) | ||
|---|---|---|---|
| COP (13) | FATmax (9) | Control (8) | |
| Age (yr) | 21.5 ± 2.0 | 22.2 ± 3.4 | 22.8 ± 0.8 |
| Morphological indices | |||
| Height (cm) | 163.4 ± 6.3 | 164.1 ± 5.8 | 161.0 ± 6.8 |
| Weight (kg) | 70.0 ± 11.2 | 70.1 ± 6.2 | 68.7 ± 7.8 |
| Waist circumference (cm) | 82.7 ± 9.2 | 82.9 ± 4.4 | 82.1 ± 5.2 |
| Hip circumference (cm) | 103.7 ± 8.0 | 103.4 ± 4.4 | 103.6 ± 9.2 |
| BMI (kg/m2) | 26.14 ± 3.04 | 26.12 ± 3.25 | 26.49 ± 2.17 |
| Waist to hip ratio | 0.80 ± 0.04 | 0.80 ± 0.03 | 0.79 ± 0.03 |
| Waist-to-height ratio | 0.51 ± 0.05 | 0.51 ± 0.04 | 0.51 ± 0.03 |
| Body composition indices | |||
| Body fat percentage (%) | 38.78 ± 4.48 | 40.17 ± 3.52 | 39.42 ± 1.67 |
| Abdominal fat (g) | 1906.69 ± 638.92 | 1968.78 ± 526.37 | 1935.60 ± 348.01 |
| Fat mass (kg) | 27.38 ± 6.29 | 28.23 ± 4.32 | 27.08 ± 3.13 |
| Lean body mass (kg) | 43.20 ± 6.58 | 42.34 ± 4.24 | 42.04 ± 7.85 |
| Blood indices | |||
| TC (mmol/L) | 4.70 ± 0.59 | 4.67 ± 0.45 | 4.45 ± 0.65 |
| TG (mmol/L) | 0.93 ± 0.36 | 1.25 ± 0.64 | 0.95 ± 0.55 |
| HDL-C (mmol/L) | 1.44 ± 0.31 | 1.36 ± 0.29 | 1.36 ± 0.05 |
| LDL-C (mmol/L) | 2.71 ± 0.56 | 2.69 ± 0.26 | 2.54 ± 0.47 |
| Apo AI (mg/dL) | 110.87 ± 16.09 | 99.40 ± 17.77 | 108.83 ± 16.48 |
| Apo B (mg/dL) | 95.37 ± 16.53 | 97.68 ± 15.26 | 82.00 ± 16.82 |
| Apo B/Apo AI | 0.89 ± 0.26 | 1.01 ± 0.24 | 0.75 ± 0.05 |
| LPL (ng/mL) | 1.34 ± 0.20 | 1.38 ± 0.24 | 1.43 ± 0.21 |
| Maximal oxygen uptake | |||
| VO2max (mL/kg/min) | 34.9 ± 6.6 | 35.2 ± 7.6 | 35.8 ± 5.2 |
Data are presented as mean ± SD, unless otherwise indicated. N, the number of participants; BMI, body mass index; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Apo AI, apolipoprotein AI; Apo B, apolipoprotein B; LPL, lipoprotein lipase; VO2max, maximal oxygen uptake.